Specialty Pharma Journal Specialty, Precision & Technology
(Friday) – Cancer Research UK today announced the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology (CRT), and Celgene Corporation, to discover, develop and commercialize new anti-cancer treatments. This arrangement represents an expansion of Cancer Research Technology’s theme-based translational model that now encompasses six industry partnerships, including …
Tag Archives: Cancer Research UK
December, 2017
July, 2017
-
7 July
Simple Test Predicts Return of Bladder Cancer
Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research* published in the British Journal of Cancer today (Friday). Researchers from the University Hospital of Lyon tested the urine of 348 bladder cancer patients for a faulty protein called …
June, 2017
-
21 June
Study Estimates Breast and Ovarian Cancer Risk Linked to Faulty BRCA Genes
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer. The research found that the highest rates of breast cancer in women with a faulty BRCA1 gene were seen between the ages of 41-50. …
April, 2017
-
28 April
Tracking Unstable Chromosomes Helps Predict Lung Cancer’s Return
Scientists have found that unstable chromosomes within lung tumors increases the risk of cancer returning after surgery, and have used this new knowledge to detect relapse long before standard testing. These are the first findings from the Cancer Research UK-funded TRACERx* lung cancer study, published today (Wednesday) in the New …
March, 2017
-
27 March
New Era in Precision Medicine for Pancreatic Cancer
The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK. The investment will support the PRECISION Panc* project which aims to develop …
February, 2017
-
1 February
Big Data Brings Breast Cancer Research Forwards by ‘Decades’
Scientists have created a ‘map’ linking the shape of breast cancer cells to genes turned on and off, and matched it to real disease outcomes, which could one day help doctors select treatments, according to a study published in Genome Research today (Wednesday).* In a revolutionary new approach, Cancer Research …
November, 2016
-
7 November
Tumor Cells in Blood Samples Could Predict Prostate Cancer Spread
Researchers have found a group of circulating tumor cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research* presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. This is the first time these cell types have been …
July, 2016
-
11 July
International Collaboration to Create New Cancer Models to Accelerate Research
An international project to develop a large, globally accessible, bank of new cancer cell culture models for the research community launches today. The National Cancer Institute (NCI), Cancer Research UK, the Wellcome Trust Sanger Institute and the foundation Hubrecht Organoid Technology are joining forces to develop the Human Cancer Models Initiative (HCMI) …
March, 2016
-
7 March
Blood Test May Give Early Warning of Skin Cancer Relapse
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today. Scientists from the Cancer Research UK Manchester Institute studied the DNA shed by tumours into the bloodstream – called circulating tumour DNA …
October, 2015
-
30 October
AstraZeneca’s Ovarian Cancer Drug Shows Promise in Prostate Cancer
A small UK clinical trial has found that a drug developed to target inherited gene faults could benefit some men whose prostate cancer has spread. The researchers now hope to confirm the findings in a second trial, which will test the theory of ‘precision medicine’ for prostate cancer patients further. Olaparib …